title: Assessment and management of gastrointestinal toxicities and lab abnormalities related to targeted therapy.
abstract: OBJECTIVE
  To identify the most common gastrointestinal toxicities and laboratory abnormalities associated with targeted therapies, as well as the assessment and management necessary to minimize adverse events related to these side effects.
  
  
  METHODS
  Peer-reviewed articles and national guidelines for oncology practice.
  
  
  CONCLUSIONS
  Common toxicities of diarrhea, mucositis, and laboratory abnormalities are often associated with the use of targeted agents and require skilled assessment and early management interventions to prevent severe complications or treatment interruption.
  
  
  CONCLUSIONS
  Emerging trends focused on targeted therapy increase the importance of the oncology nurse's role in assessment, education, and evidenced-based recommendations to meet patient needs.
authors.forename: Erica A
authors.initials: EA
authors.lastname: Fischer-Cartlidge
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects*; D041981:Gastrointestinal Tract / Q000187:drug effects* / Q000503:physiopathology; D006801:Humans; D058990:Molecular Targeted Therapy / Q000009:adverse effects*; D009369:Neoplasms / Q000188:drug therapy*
chemical_list: D000970:Antineoplastic Agents
keywords: Targeted therapy; gastrointestinal; laboratory abnormalities; management; toxicity